← Leaderboards
Ryan T Gill
University Of Colorado At Boulder
$1,865,698
Attributed
$3,201,874
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $738.3K · FY2005–18$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,201,874 · 4
By mechanism
R01$1,781,568 · 1
R21$856,622 · 2
K25$563,684 · 1
Top collaborators
- Dan L. Feldheim4 shared
- Christian C Melander4 shared
- Daniel Vincent Zurawski4 shared
Most similar at University Of Colorado At Boulder
Same institution · by research overlap
- Shelley D. Copley$8,703,593
- Mark Winey$13,866,068
- Shelley D Copley$2,908,343
- David S Fay$17,590,716
Others in their field
Top investigators on “Pseudomonas Aeruginosa”
- Henry F Chambers · Duke University$46,515,637
- Vance G Fowler · Duke University$46,515,637
- Deborah T Hung · Massachusetts General Hospital$24,051,776
- Ryan Cirz · Revagenix, Inc.$22,711,751
- Daniel J Wozniak · Ohio State University$19,184,613
- Alan R Hauser · Northwestern University$18,516,245
Research focus
Pseudomonas AeruginosaDrug ResistanceResistancePharmaceutical PreparationsLibrariesStructureEvolutionAntibioticsGenomicsGrowthOrganismFutureSmall MoleculeCommunicable DiseasesResearch StudyScreeningCombatPathogenBaseBacteriaEscherichia ColiCaliberCommunitiesDensity
Grant awards (12)
Multiplex sequence to activity mapping at the pathway scale$192,500
R21 · FY2018 · AI · contact PI
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati$507,293
R01 · FY2017 · AI
Multiplex sequence to activity mapping at the pathway scale$231,000
R21 · FY2017 · AI · contact PI
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati$436,530
R01 · FY2016 · AI
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati$412,744
R01 · FY2015 · AI
Gold Nanocrystal Antibiotics for the Treatment of Multidrug-resistant Gram Negati$425,001
R01 · FY2014 · AI
BioMolecular Networks in Antibiotic Resistance Evolution$140,921
K25 · FY2008 · AI · contact PI
BioMolecular Networks in Antibiotic Resistance Evolution$140,921
K25 · FY2007 · AI · contact PI
BioMolecular Networks in Antibiotic Resistance Evolution$140,921
K25 · FY2006 · AI · contact PI
BioMolecular Networks in Antibiotic Resistance Evolution$140,921
K25 · FY2005 · AI
Using Genomics to Identify Antibiotic Sensitivity Genes$220,433
R21 · FY2004 · AI
Using Genomics to Identify Antibiotic Sensitivity Genes$212,689
R21 · FY2003 · AI